عرض مصدر آناكينرا

{{صندوق معلومات دواء
| Verifiedfields = changed
| verifiedrevid = 457810558
| IUPAC_name = Recombinant human Interleukin-1 receptor antagonist protein; syn. N2-l-methionyl-interleukin 1 receptor antagonist (human isoform x reduced)
| image = Anakinra.png
| width = 220

<!--Clinical data-->
| tradename = Kineret
| Drugs.com = {{drugs.com|monograph|anakinra}}
| MedlinePlus = a602001
| pregnancy_AU = B1
| pregnancy_US = B
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = Subcutaneous

<!--Pharmacokinetic data-->
| bioavailability = 95%
| protein_bound =  
| metabolism = predominantly renal
| elimination_half-life = 4-6 hrs

<!--Identifiers-->
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = NA
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 143090-92-0
| ATC_prefix = L04
| ATC_suffix = AC03
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00026
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 9013DUQ28K
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02934
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201570

<!--Chemical data-->
| C=759 | H=1186 | N=208 | O=232 | S=10 
| molecular_weight = 17,257.6 g/mol
}}
'''آناكينرا''' هو [[دواء]] [[مناهضة (أدوية)|مضاد]] لمستقبل [[إنترلوكين 1]]، ويستخدم في علاج [[التهاب المفاصل الروماتويدي]].<ref name="pmid16396977">{{استشهاد بدورية محكمة |مؤلف=Fleischmann RM, Tesser J, Schiff MH |عنوان=Safety of extended treatment with anakinra in patients with rheumatoid arthritis |صحيفة=Annals of the rheumatic diseases |المجلد=65 |العدد=8 |صفحات=1006–12 |تاريخ=أغسطس 2006 |pmid=16396977 |doi=10.1136/ard.2005.048371 |مسار= https://ard.bmj.com/content/65/8/1006.long |pmc=1798263|إظهار المؤلفين=etal|مسار أرشيف= https://web.archive.org/web/20191208030922/http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=16396977|تاريخ أرشيف=2019-12-08}}</ref>